Hyperaldosteronism

Textbook of Endocrine Surgery

Volumn , Issue , 2005, Pages 595-603

  Obara, Takao ^a,b   Ito, Yukio ^a,b   Iihara, Masatoshi ^a,b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN S MEDICAL UNIVERSITY MEDICAL CENTER EAST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349872629     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0139-7.50072-7     Document Type: Chapter

References (84)

1. Conn J Part I. Painting background. Part II. Primary aldosteronism, a new clinical syndrome 1954. J Lab Clin Med 1990, 116:253.
2. Ganguly A Primary aldosteronism. N Engl J Med 1998, 339:1828.
3. Young WF Primary aldosteronism: A common and curable form of hypertension. Cardiol Rev 1999, 7:207.
4. Ganguly A, Zager P, Luetscher J Primary aldosteronism due to unilateral adrenal hyperplasia. J Clin Endocrinol Metab 1980, 51:1190.
5. Irony I, Kater C, Biglieri E, et al. Correctable subsets of primary aldosteronism. Am J Hypertens 1990, 3:576.
6. Arteaga E, Biglieri E, Kater C, et al. Aldosterone-producing adrenocortical carcinoma. Preoperative recognition and course in three cases. Ann Intern Med 1984, 101:316.
7. Yoshimoto T, Naruse M, Ito Y, et al. Adrenocortical carcinoma manifesting pure primary aldosteronism: A case report and analysis of steroidogenic enzymes. J Endocrinol Invest 2000, 23:112.
8. Lifton RP, Dluhy RG, Powers M, et al. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet 1992, 2:66.
9. Sutherland DJ, Ruse JL, Laidlaw JC Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J 1966, 95:1109.
10. Stowasser M, Gordon RD, Tunny TJ, et al. Familial hyperaldos-teronism type II: Five families with a new variety of primary aldosteronism. Clin Exp Pharmacol Physiol 1992, 19:319.
11. Stowasser M, Gunasekera TG, Gordon RD Familial varieties of primary aldosteronism. Clin Exp Pharmacol Physiol 2001, 28:1087.
12. Young WJ, Klee G Primary aldosteronism. Diagnostic evaluation. Endocrinol Metab Clin North Am 1988, 14:367.
13. Obara T, Ito Y, Okamoto T, et al. Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism. Surgery 1992, 112:987.
14. Ferriss J, Brown J, Fraser R, et al. Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration. Br Med J 1975, 1:135.
15. Hunt T, Schmbelan M, Biglieri E Selection of patients and operative approach in primary aldosteronism. Ann Surg 1975, 182:353.
16. Gleason PE, Weinberger MH, Pratt JH, et al. Evaluation of diagnostic tests in the differential diagnosis of primary aldosteronism: Unilateral adenoma versus bilateral micronodular hyperplasia. J Urol 1993, 150:1365.
17. Lins P, Adamson U Primary aldosteronism. A follow-up study of 28 cases of surgically treated aldosterone-producing adenomas. Acta Med Scand 1987, 221:275.
18. Vetter H, Fischer M, Galanski M, et al. Primary aldosteronism: Diagnosis and noninvasive lateralization procedures. Cardiology 1985, 72:57.
19. Celen O, O'Brien MJ, Melby JC, et al. Factors influencing outcome of surgery for primary aldosteronism. Arch Surg 1996, 131:646.
20. Favia G, Lumachi F, Scarpa V, et al. Adrenalectomy in primary aldosteronism: A long-term follow-up study in 52 patients. World J Surg 1992, 16:680.
21. Lo CY, Tam PC, Kung AW, et al. Primary aldosteronism. Results of surgical treatment. Ann Surg 1996, 224:125.
22. Milsom S, Espiner E, Nicholls M, et al. The blood pressure response to unilateral adrenalectomy in primary aldosteronism. Q J Med 1986, 61:1141.
23. Proye CA, Mulliez EA, Carnaille BM, et al. Essential hypertension: First reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?. Surgery 1998, 124:1128.
24. Huang YY, Hsu BR, Tsai JS Paralytic myopathy-A leading clinical presentation for primary aldosteronism in Taiwan. J Clin Endocrinol Metab 1996, 81:4038.
25. Gordon RD, Stowasser M Familial forms broaden the horizons for primary aldosteronism. Trends Endocrinol Metab 1998, 9:220.
26. Beckers A, Abs R, Willems PJ, et al. Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): Loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus. J Clin Endocrinol Metab 1992, 75:564.
27. Gould E, Albores SJ, Shuman J Pituitary prolactinoma, pancreatic glucagonomas, and aldosterone-producing adrenal cortical adenoma: A suggested variant of multiple endocrine neoplasia type I. Hum Pathol 1987, 18:1290.
28. Strauch G, Vallotton MB, Touitou Y, et al. The renin-angiotensin-aldosterone system in normotensive and hypertensive patients with acromegaly. N Engl J Med 1972, 287:795.
29. Hiramatsu K, Yamada T, Yukimura Y, et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Arch Intern Med 1981, 141:1589.
30. Streeten DH, Tomycz N, Anderson GH Reliability of screening methods for the diagnosis of primary aldosteronism. Am J Med 1979, 67:403.
31. Gordon RD, Stowasser M, Tunny TJ, et al. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994, 21:315.
32. Lim PO, Rodgers P, Cardale K, et al. Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 1999, 353:40.
33. Loh KC, Koay ES, Khaw MC, et al. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000, 85:2854.
34. Young WFJ Primary aldosteronism: Update on diagnosis and treatment. Endocrinologist 1997, 7:213.
35. Bravo E Primary aldosteronism. Issues in diagnosis and management. Endocrinol Metab Clin North Am 1994, 23:271.
36. Melby JC Clinical review 1: Endocrine hypertension. J Clin Endocrinol Metab 1989, 69:697.
37. Gordon RD, Ziesak MD, Tunny TJ, et al. Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers. Clin Exp Pharmacol Physiol 1993, 20:296.
38. Hamlet SM, Tunny TJ, Woodland E, et al. Is aldosterone/renin ratio useful to screen a hypertensive population for primary aldosteronism?. Clin Exp Pharmacol Physiol 1985, 12:249.
39. Weinberger MH, Fineberg NS The diagnosis of primary aldosteronism and separation of two major subtypes. Arch Intern Med 1993, 153:2125.
40. Young WF Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 2000, 29:159.
41. McKenna TJ, Sequeira SJ, Heffernan A, et al. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab 1991, 73:952.
42. Blumenfeld JD, Sealey JE, Schlussel Y, et al. Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med 1994, 121:877.
43. Weinberger MH, Grim CE, Hollifield JW, et al. Primary aldosteronism: Diagnosis, localization, and treatment. Ann Intern Med 1979, 90:386.
44. Lyons DF, Kem DC, Brown RD, et al. Single dose captopril as a diagnostic test for primary aldosteronism. J Clin Endocrinol Metab 1983, 57:892.
45. Ganguly A Prevalence of primary aldosteronism in unselected hypertensive populations: Screening and definitive diagnosis. J Clin Endocrinol Metab 2001, 86:4002.
46. Ganguly A, Melada G, Luetscher J, et al. Control of plasma aldosterone in primary aldosteronism: Distinction between adenoma and hyperplasia. J Clin Endocrinol Metab 1973, 37:765.
47. McLeod M, Thompson N, Gross M, et al. Idiopathic aldosteronism masquerading as discrete aldosterone-secreting adrenal cortical neoplasms among patients with primary aldosteronism. Surgery 1989, 106:1161.
48. Nomura K, Toraya S, Horiba N, et al. Plasma aldosterone response to upright posture and angiotensin ii infusion in aldosterone-producing adenoma. J Clin Endocrinol Metab 1992, 75:323.
49. Kem DC, Tang K, Hanson CS, et al. The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorti-costerone levels. J Clin Endocrinol Metab 1985, 60:67.
50. Biglieri E, Irony I, Kater C Identification and implications of new types of mineralocorticoid hypertension. J Steroid Biochem 1989, 32:199.
51. Weigel RJ, Wells SA, Gunnells JC, et al. Surgical treatment of primary hyperaldosteronism. Ann Surg 1994, 219:347.
52. Doppman JL, Gill JJ, Miller DL, et al. Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: Reliability of CT. Radiology 1992, 184:677.
53. Gross M, Shapiro B Scintigraphic studies in adrenal hypertension. Semin Nucl Med 1989, 19:122.
54. Hollak CE, Prummel MF, Tiel-van Buul MM Bilateral adrenal tumours in primary aldosteronism: Localization of a unilateral aldosteronoma by dexamethasone suppression scan. J Intern Med 1991, 229:545.
55. Nomura K, Kusakabe K, Maki M, et al. Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppression scintigraphy: Relationship to adenoma size and functional activity. J Clin Endocrinol Metab 1990, 71:825.
56. Harper R, Ferrett CG, McKnight JA, et al. Accuracy of CT scanning and adrenal vein sampling in the pre-operative localization of aldosterone-secreting adrenal adenomas. QJM 1999, 92:643.
57. Magill SB, Raff H, Shaker JL, et al. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 2001, 86:1066.
58. Melby JC Diagnosis of hyperaldosteronism. Endocrinol Metab Clin North Am 1991, 20:247.
59. Phillips JL, Walther MM, Pezzullo JC, et al. Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 2000, 85:4526.
60. Young WF, Stanson AW, Grant CS, et al. Primary aldosteronism: Adrenal venous sampling. Surgery 1996, 120:913.
61. Doppman JL, Gill JR Hyperaldosteronism: Sampling the adrenal veins. Radiology 1996, 198:309.
62. Gagner M Laparoscopic adrenalectomy. Surg Clin North Am 1996, 76:523.
63. Kebebew E, Siperstein AE, Duh QY Laparoscopic adrenalectomy: The optimal surgical approach. J Laparoendosc Adv Surg Tech A 2001, 11:409.
64. Marescaux J, Mutter D, Wheeler MH Laparoscopic right and left adrenalectomies. Surgical procedures. Surg Endosc 1996, 10:912.
65. Gagner M, Lacroix A, Prinz RA, et al. Early experience with laparoscopic approach for adrenalectomy. Surgery 1993, 114:1120.
66. Higashihara E, Tanaka Y, Horie S, et al. Laparoscopic adrenalectomy: The initial 3 cases. J Urol 1993, 149:973.
67. Suzuki K, Kageyama S, Ueda D, et al. Laparoscopic adrenalectomy: Clinical experience with 12 cases. J Urol 1993, 150:1099.
68. Brunt LM, Doherty GM, Norton JA, et al. Laparoscopic adrenalectomy compared to open adrenalectomy for benign adrenal neoplasms. J Am Coll Surg 1996, 183:1.
69. Guazzoni G, Montorsi F, Bocciardi A, et al. Transperitoneal laparoscopic versus open adrenalectomy for benign hyperfunctioning adrenal tumors: A comparative study. J Urol 1995, 153:1597.
70. Korman JE, Ho T, Hiatt JR, et al. Comparison of laparoscopic and open adrenalectomy. Am Surg 1997, 63:908.
71. Linos DA, Stylopoulos N, Boukis M, et al. Anterior, posterior, or laparoscopic approach for the management of adrenal diseases?. Am J Surg 1997, 173:120.
72. Prinz RA A comparison of laparoscopic and open adrenalectomies. Arch Surg 1995, 130:489.
73. Shen WT, Lim RC, Siperstein AE, et al. Laparoscopic vs open adrenalectomy for the treatment of primary hyperaldosteronism. Arch Surg 1999, 134:628.
74. Al-Sobhi S, Peschel R, Bartsch G, et al. Partial laparoscopic adrenalectomy for aldosterone-producing adenoma: Short-and long-term results. J Endourol 2000, 14:497.
75. Imai T, Tanaka Y, Kikumori T, et al. Laparoscopic partial adrenalectomy. Surg Endosc 1999, 13:343.
76. Kok KY, Yapp SK Laparoscopic adrenal-sparing surgery for primary hyperaldosteronism due to aldosterone-producing adenoma. Surg Endosc 2002, 16:108.
77. Nakada T, Kubota Y, Sasagawa I, et al. Therapeutic outcome of primary aldosteronism: Adrenalectomy versus enucleation of aldosterone-producing adenoma. J Urol 1995, 153:1775.
78. Blumenfeld JD, Vaughan ED Diagnosis and treatment of primary aldosteronism. World J Urol 1999, 17:15.
79. Horky K, Widimsky JJ, Hradec E, et al. Long-term results of surgical and conservative treatment of patients with primary aldosteronism. Exp Clin Endocrinol 1987, 90:337.
80. Lim RJ, Nakayama D, Biglieri E, et al. Primary aldosteronism: Changing concepts in diagnosis and management. Am J Surg 1986, 152:116.
81. Sawka AM, Young WF, Thompson GB, et al. Primary aldosteronism: Factors associated with normalization of blood pressure after surgery. Ann Intern Med 2001, 135:258.
82. Ito Y, Fujimoto Y, Obara T, et al. Clinical significance of associated nodular lesions of the adrenal in patients with aldosteronoma. World J Surg 1990, 14:330.
83. Stowasser M, Klemm SA, Tunny TJ, et al. Response to unilateral adrenalectomy for aldosterone-producing adenoma: Effect of potassium levels and angiotensin responsiveness. Clin Exp Pharmacol Physiol 1994, 21:319.
84. Streeten D, Anderson GJ, Wagner S Effect of age on response of secondary hypertension to specific treatment. Am J Hypertens 1990, 3:360.